Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score cases in a reproducibility study. This study aimed to evaluate the reproducibility of sTILs assessment using this scoring aid in cases from routine practice and to explore the potential of the tool to overcome variability in scoring. Twenty-three breast pathologists scored sTILs in digitized slides of 49 TNBC biopsies using the scoring aid. Subsequently, fields of view (FOV) from each case were selected by one pathologist and scored by the group using the tool. Inter-observer agreement was good for absolute sTILs (ICC 0.634, 95% CI 0.539–0.735, p < 0.001) but was poor to fair using binary cutpoints. sTILs heterogeneity was the main contributor to disagreement. When pathologists scored the same FOV from each case, inter-observer agreement was excellent for absolute sTILs (ICC 0.798, 95% CI 0.727–0.864, p < 0.001) and good for the 20% (ICC 0.657, 95% CI 0.561–0.756, p < 0.001) and 40% (ICC 0.644, 95% CI 0.546–0.745, p < 0.001) cutpoints. However, there was a wide range of scores for many cases. Reproducibility scoring sTILs is good when the scoring aid is used. Heterogeneity is the main contributor to variance and will need to be overcome for analytic validity to be achieved.

Intra-tumour heterogeneity is one of the main sources of inter-observer variation in scoring stromal tumour infiltrating lymphocytes in triple negative breast cancer / Kilmartin D.; O'Loughlin M.; Andreu X.; Bago-Horvath Z.; Bianchi S.; Chmielik E.; Cserni G.; Figueiredo P.; Floris G.; Foschini M.P.; Kovacs A.; Heikkila P.; Kulka J.; Laenkholm A.-V.; Liepniece-Karele I.; Marchio C.; Provenzano E.; Regitnig P.; Reiner A.; Ryska A.; Sapino A.; Stovgaard E.S.; Quinn C.; Zolota V.; Webber M.; Roshan D.; Glynn S.A.; Callagy G.. - In: CANCERS. - ISSN 2072-6694. - ELETTRONICO. - 13:17(2021), pp. 4410.4410-4410.4410. [10.3390/cancers13174410]

Intra-tumour heterogeneity is one of the main sources of inter-observer variation in scoring stromal tumour infiltrating lymphocytes in triple negative breast cancer

Foschini M. P.
Conceptualization
;
Sapino A.;Quinn C.;
2021

Abstract

Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score cases in a reproducibility study. This study aimed to evaluate the reproducibility of sTILs assessment using this scoring aid in cases from routine practice and to explore the potential of the tool to overcome variability in scoring. Twenty-three breast pathologists scored sTILs in digitized slides of 49 TNBC biopsies using the scoring aid. Subsequently, fields of view (FOV) from each case were selected by one pathologist and scored by the group using the tool. Inter-observer agreement was good for absolute sTILs (ICC 0.634, 95% CI 0.539–0.735, p < 0.001) but was poor to fair using binary cutpoints. sTILs heterogeneity was the main contributor to disagreement. When pathologists scored the same FOV from each case, inter-observer agreement was excellent for absolute sTILs (ICC 0.798, 95% CI 0.727–0.864, p < 0.001) and good for the 20% (ICC 0.657, 95% CI 0.561–0.756, p < 0.001) and 40% (ICC 0.644, 95% CI 0.546–0.745, p < 0.001) cutpoints. However, there was a wide range of scores for many cases. Reproducibility scoring sTILs is good when the scoring aid is used. Heterogeneity is the main contributor to variance and will need to be overcome for analytic validity to be achieved.
2021
Intra-tumour heterogeneity is one of the main sources of inter-observer variation in scoring stromal tumour infiltrating lymphocytes in triple negative breast cancer / Kilmartin D.; O'Loughlin M.; Andreu X.; Bago-Horvath Z.; Bianchi S.; Chmielik E.; Cserni G.; Figueiredo P.; Floris G.; Foschini M.P.; Kovacs A.; Heikkila P.; Kulka J.; Laenkholm A.-V.; Liepniece-Karele I.; Marchio C.; Provenzano E.; Regitnig P.; Reiner A.; Ryska A.; Sapino A.; Stovgaard E.S.; Quinn C.; Zolota V.; Webber M.; Roshan D.; Glynn S.A.; Callagy G.. - In: CANCERS. - ISSN 2072-6694. - ELETTRONICO. - 13:17(2021), pp. 4410.4410-4410.4410. [10.3390/cancers13174410]
Kilmartin D.; O'Loughlin M.; Andreu X.; Bago-Horvath Z.; Bianchi S.; Chmielik E.; Cserni G.; Figueiredo P.; Floris G.; Foschini M.P.; Kovacs A.; Heikkila P.; Kulka J.; Laenkholm A.-V.; Liepniece-Karele I.; Marchio C.; Provenzano E.; Regitnig P.; Reiner A.; Ryska A.; Sapino A.; Stovgaard E.S.; Quinn C.; Zolota V.; Webber M.; Roshan D.; Glynn S.A.; Callagy G.
File in questo prodotto:
File Dimensione Formato  
TILs 2021.pdf

accesso aperto

Descrizione: pdf finale
Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.59 MB
Formato Adobe PDF
1.59 MB Adobe PDF Visualizza/Apri
cancers-13-04410-s001.zip

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per accesso libero gratuito
Dimensione 470.66 kB
Formato Zip File
470.66 kB Zip File Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/863254
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 9
social impact